ADMA
ADMA Biologics (ADMA) Investor Questions
Review ADMA Biologics (ADMA) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- ADMA Biologics
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 82
- Annual revenue
- $510.17M
- Annual net income
- $146.93M
- Annual free cash flow
- $27.82M
ADMA Biologics (ADMA) Investor Questions research
ADMA Biologics trades under the ticker ADMA. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ADMA through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.